Anika Therapeutics
Price & Volume
Stats
See more52W Range | $7.87-$18.37 |
Market Cap | $141M |
Shares Short | 331,508 |
Financials
See moreRevenue (12 Mos) | $112.8M |
Revenue Growth (YoY) | -5.9% |
Gross Profit (12 Mos) | $62.3M |
Diluted EPS | -$0.99 |
News
See moreYahoo Finance • 23 days ago
Anika (ANIK) Q3 2025 Earnings Call Transcript
Yahoo Finance • 23 days ago
Anika Reports Third Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders
Yahoo Finance • 2 months ago
Notable Friday Option Activity: SIRI, BTBT, FCX
About
CEO | Dr. Cheryl Renee Blanchard Ph.D. |
CFO | Mr. Stephen D. Griffin |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 288 |
